CURE’s neuroendocrine cancer page features the latest cancer news and updates on neuroendocrine cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in neuroendocrine cancer.
March 26th 2025
The FDA has approved Cabometyx for some patients 12 years old and older with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors.